Nanogenics Limited

Active07636591 Private limited company
Incorporated
17 May 2011 (15 years)
Previously known as
Nanogenic Solutions Limited (until 18 June 2018)
This list may be incomplete. See all names on Companies House
Industry
Research and experimental development on biotechnology (72110)
Directors
Luke Cairns
Paul Murray
Accounts type
Micro entity
Region
Greater London
Address
C/o Arch Law Level 2 Huckletree
8 Bishopsgate
London
EC2N 4BQ

Filing status

Accounts due
30 September 2027
Last accounts
31 December 2025
Conf. stmt due
22 July 2027
Last conf. stmt
8 July 2026

Officers 2 active

Officer details are public data from the Companies House register.

Cairns, Luke
Director · Appointed 5 October 2023
British
Born May 1978 (48)
Murray, Paul
Director · Appointed 10 August 2021
British
Born May 1964 (62)
Officer history (6 former)
1 October 2026
Resigned Theobald, Nigel James as Director
9 July 2024
Resigned Newman, Simon Paul, Dr as Director
5 October 2023
Resigned Lane, Jonathan Douglas as Director
5 October 2023
Appointed Theobald, Nigel James as Director
5 October 2023
Appointed Cairns, Luke as Director
10 August 2021
Resigned Walker, Alan Keith, Dr as Director
10 August 2021
Appointed Murray, Paul as Director
18 September 2020
Appointed Lane, Jonathan Douglas as Director
17 May 2020
Resigned Mcdonald, Ian Andrew as Director
11 May 2018
Appointed Mcdonald, Ian Andrew as Director
11 May 2018
Appointed Walker, Alan Keith, Dr as Director
11 May 2018
Appointed Newman, Simon Paul, Dr as Director
11 May 2018
Resigned Lane, Jonathan Douglas as Director
17 May 2011
Appointed Lane, Jonathan Douglas as Director

Ownership 1 active

People and entities with significant control, from the Companies House PSC register

Corporate entity · Notified 5 October 2023
Owns 50–75% of shares
Holds 50–75% of voting rights
Corporate
Reg. no. 01435584
Former controllers (3)
5 October 2023
Ceased Ryboquin Company Ltd — Owns 50–75% of shares
11 May 2018
Ceased Applisci Ltd — Owns 25–50% of shares
11 May 2018
Ceased Stephen Lewis Hart — Owns 25–50% of shares

Group structure 4 companies

Ownership group derived from the Companies House PSC register

N4 Pharma UK Limited Owns 75–100% of shares
Nanogenics Limited This company Owns 50–75% of shares
Thalia Therapeutics UK Ltd Owns 75–100% of shares

Financials

Current Ratio
54.0x

Trend

Shareholder Funds
£0 £50k £100k 2020 2021 £40,564 £57,281
Balance sheet detail
20212020
Current Assets£58,361£44,814
Creditors (< 1 year)£1,080£4,250
Net Current Assets£57,281£40,564
Shareholder Funds£57,281£40,564

Filings

Recent filings only. See the full history on Companies House

Show all recent filings

Some other companies at this address

Other companies in this industry

By trade and location

New companies in London →

Explore the largest companies

Largest companies in London, UK →

Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →

← Back to companies Official record on Companies House ↗

Already have an account?

Create your account

Save searches and get the weekly email of new matches.

First name is required.
Last name is required.
Enter an email address like name@example.com.
Must be at least 8 characters. Password must be at least 8 characters.

Already have an account?